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1 
ABSTRACT 
Reconsolidation normally functions to update and maintain memories in the long-term. 
However, this process can be disrupted pharmacologically to weaken memories. Exploiting 
such experimental amnesia to disrupt the maladaptive reward memories underpinning 
addiction may provide a novel therapeutic avenue to prevent relapse. Here we tested whether 
targeted disruption of the reconsolidation of instrumental (operant) lever pressing for cocaine 
resulted in protection against different forms of relapse in a rat self-administration model. We 
first confirmed that systemic injection of the non-competitive N-methyl–D-aspartate receptor 
antagonist MK-801 did impair reconsolidation to reduce spontaneous instrumental drug-
seeking memory at test. This deficit was not rescued by pharmacological induction of stress 
with the anxiogenic α2-noradrenergic receptor antagonist yohimbine. In contrast, cocaine-
seeking was restored to control levels following priming with cocaine itself, or presentation 
of a cocaine-associated cue. These results suggest that while stress-induced relapse can be 
reduced by disruption of instrumental memory reconsolidation, the apparent sparing of the 
pavlovian cue-drug memory permitted other routes to relapse. Therefore, future 
reconsolidation-based therapeutic strategies for addictive drug-seeking may need to target 
both instrumental and pavlovian memories.
1 
INTRODUCTION 1 
Memories are constantly evolving through a constructive process that serves to update their 2 
content. One core mechanism of memory updating is believed to be memory reconsolidation 3 
[1; 2]. Following appropriate retrieval, believed to involve some form of prediction error [3], 4 
a memory can be destabilised, requiring that it is subsequently restabilised in a 5 
reconsolidation process that necessitates activity at N-methyl–D-aspartate receptors 6 
(NMDARs), gene expression, and protein synthesis [4]. Pharmacologically impairing the 7 
restabilisation of a memory during the reconsolidation phase can induce amnesia. This 8 
finding has generated much interest in treating disorders underpinned by maladaptive 9 
memories [5; 6; 7]. 10 
 11 
It has been suggested that addictions are driven by the formation of a maladaptive ‘habit’ 12 
memory [8], which supports the underlying behavioural compulsion to seek drugs, regardless 13 
of consequences, that characterises the state of addiction [9]. Importantly, both instrumental 14 
(operant) associations and pavlovian conditioned stimuli (CSs) contribute to the performance 15 
and maintenance of drug-seeking behaviours [10; 11]. This is critical in understanding 16 
relapse, as each bout of relapse is often precipitated by exposure to stress, the drug itself or a 17 
drug-associated CS [12]. 18 
. 19 
Addictive drug memory reconsolidation studies have predominantly focussed on pavlovian 20 
cue-drug memories, showing that these memories can be disrupted to reduce cue-induced 21 
drug seeking and relapse in both animal models [13] and human populations [14]. However, 22 
given that relapse can also occur following induction of stress [15] or re-exposure to the drug 23 
itself [16], and that impairment of pavlovain cocaine memory reconsolidation does not appear 24 
2 
to protect against cocaine-induced relapse [17], the potential for long-lasting therapeutic 25 
benefit may be limited. 26 
 27 
As addictive drug seeking requires intact instrumental memory and expression, it is possible 28 
that targeting the instrumental memory for reconsolidation disruption might provide more 29 
robust protection against stress- and drug-induced relapse. We have previously demonstrated 30 
that instrumental memories can be impaired by the NMDAR antagonist MK-801, under 31 
conditions of brief training with both sucrose and intravenous cocaine reinforcement [18], 32 
and more extensive sucrose reinforcement [19], findings that are consistent with the effects of 33 
NMDAR antagonists to impair memory reconsolidation in other settings [20; 21; 22; 23]. In 34 
the present study, we used an intravenous (i.v.) self-administration paradigm to investigate: 35 
1) whether reconsolidation-disruption of instrumental cocaine memory can reduce 36 
spontaneous drug-seeking after an established period of self-administration; and 2) whether 37 
reconsolidation-disruption of instrumental memory could also provide resistance to relapse 38 
triggered via pharmacological stress (mimicking physiological and psychological stress with 39 
the anxiogenic α2-noradrenergic receptor antagonist yohimbine [24; 25], re-exposure to 40 
cocaine, or presentation of a drug-associated cue. 41 
 42 
 43 
 44 
  45 
3 
METHODS AND MATERIALS 46 
Subjects were 124 experimentally naïve male Hooded-Lister rats (Charles River, UK) 47 
weighing 250-350g (median 275g) at the beginning of the experiment. Rats were kept in a 48 
conventional animal facility on a 12hr light/dark cycle (lights on 0700), housed in quads in 49 
individually ventilated cages with two levels; the lower contained aspen chip bedding. 50 
Environmental enrichment was available in the form of wood chew blocks and paper house. 51 
Food and water were provided ad libitum. Experimental sessions took place 0800–1600 each 52 
day. At the end of the experiment all animals were humanely killed via a rising concentration 53 
of CO2. All procedures were approved by a local ethical review board and carried out in 54 
accordance with the UK Animals (Scientific Procedures) Act 1986, Amendment Regulations 55 
2012 (PPL P8B15DC34 & PPL P3B19B9D2). 56 
Surgical procedures 57 
Drinking water was supplemented with the broad-spectrum antibiotic Baytril for 7d, 58 
beginning 3d pre-operatively. Rats were anaesthetised using isoflurane (5% induction, 2-3% 59 
maintenance), and administered peri- and post-operative buprenorphine; their diet was also 60 
supplemented with the non-steroidal anti-inflammatory Carprofen for 1d pre-operatively, and 61 
3d post. Rats were allowed a minimum of 7d recovery, during which they were singly housed 62 
on Puracel bedding; rats were rehoused in quads at the start of experimental procedures. 63 
Surgeries were carried out aseptically during which rats were implanted with chronic 64 
indwelling jugular vein catheters (Polyurethane Intravascular Tubing; Instech, PA) aimed at 65 
the left vena cava, secured with silk suture, and exteriorised on the dorsum with a small 66 
plastic implant (PlasticsOne, VA; 313-000BM-15-5UP/1/SPC) secured to the skin with a 1 67 
inch mesh. 68 
4 
Drugs 69 
Cocaine HCl (Macfarlane Smith Ltd, UK) was dissolved in sterile saline to a concentration of 70 
2.5 mg/ml; i.v. infusions of 0.1ml over 5.6 seconds could be obtained during training and 71 
reactivation. Infusion dosage was based upon established literature [26]. For cocaine-primed 72 
reinstatement, 10 mg/kg of cocaine solution was injected intraperitoneally (i.p.) immediately 73 
before the behavioural session; this dose is known to reinstate lever pressing for cocaine [27]. 74 
MK-801 (AbCam, UK) was dissolved in sterile saline to a concentration of 0.1 mg/ml. 30 75 
minutes prior to memory reactivation rats were injected i.p. with 0.1mg/kg of MK-801 or 76 
saline vehicle. This dose is established to disrupt instrumental memory reconsolidation [18; 77 
19]. Injections were assigned systematically by cage, randomly within each cage. 78 
Yohimbine (Sigma-Aldrich, UK) was dissolved in sterile saline to a concentration of 1.25 79 
mg/ml. For stress-induced reinstatement, yohimbine was administered 30 minutes prior to 80 
testing (1.25 mg/kg). This dose is established to reinstate drug-seeking in cocaine settings 81 
[25]. 82 
Behavioural procedures 83 
Behavioural sessions took place in 8 operant boxes (MedAssociates, VT), as described 84 
previously [18]. Prior to each session catheters were flushed with heparinised saline (0.1 ml, 85 
30 IU/ml). Catheters were then connected to an infusion pump (MedAssociates, VT) and 86 
secured with a spring tether. The study consisted of 5 experiments each with the same 87 
training and reactivation protocols, however testing was conducted in one of 5 conditions: 1) 88 
spontaneous seeking, 2) CS-induced relapse, 3) yohimbine-induced stress, 4) cocaine 89 
priming, 5) yohimbine + CS relapse. 90 
Training: Rats were trained to self-administer cocaine for 10d, on a fixed-ratio-1 schedule. 91 
Two levers were extended into the chamber; one assigned the ‘active’ cocaine-reinforced 92 
lever. Lever assignments were made systematically prior to the start of training. Active 93 
5 
responses triggered delivery of a single cocaine infusion and a 20-second illumination of a 94 
light CS above the active lever, during which the houselight went out. Both levers remained 95 
extended throughout the session, and inactive responses had no consequence. A 20-second 96 
timeout was enforced between infusions. Training sessions lasted 90 minutes, or were 97 
terminated when a maximum of 30 infusions were received. 98 
Reactivation: 48 hours after the final training day, rats were injected i.p. with MK-801, or 99 
saline, 30 minutes prior to a variable-ratio (VR5) reactivation session (Exton-McGuinness & 100 
Lee, 2015). VR5 required a random number of active lever presses to gain an infusion (mean: 101 
5, range: 1-9). Reactivation lasted 20 minutes, or until the maximum of 20 infusions was 102 
obtained. Cocaine infusions were as in training: accompanied by a CS (20 seconds) with a 103 
20-second time-out between infusions. 104 
Testing: The following day, responding was tested in a 90-minute extinction session. Levers 105 
were extended throughout, and no cocaine was delivered. The drug-paired CS was only 106 
presented in the CS-relapse and Yohimbine+CS-relapse conditions and was absent in all 107 
other tests. For yohimbine-, yohimbine+CS and cocaine-induced relapse, rats were pre-108 
treated with yohimbine or cocaine respectively. 109 
Statistical analyses 110 
Data are represented as mean ± SEM, and were analysed using JASP 0.9.1 [28]. The primary 111 
analyses were frequentist, with alpha=0.05 and 2p reported as an index of effect size. 112 
Parametric assumptions were tested using Levene’s test for equality of variances. For 113 
acquisition data, Session was included as a factor; where appropriate a Greenhouse-Geisser 114 
correction was applied to correct for sphericity violations. The primary outcome of interest 115 
was the discriminated responding between the active and inactive levers. Drug treatment was 116 
assigned pseudo-randomly to produce two groups similarly performing during training. Test 117 
sessions were analysed divided into two equal time bins [1 vs. 2] as per previous analytical 118 
6 
approaches [29]. For the Yohimbine+CS relapse experiment, the data were analysed with 119 
MK-801 and Yohimbine drug factors in independent analyses, with planned follow-up 120 
comparisons (e.g. effect of MK-801 in Yohimbine groups). We also report BFInclusion from 121 
parallel Bayesian analyses (Cauchy prior r = 0.707) as an estimate of posterior probability. 122 
4 rats were culled prior to the start of the experiment owing to problems during surgical 123 
recovery, and 7 during training due to biological rejection of catheters. 8 rats were excluded 124 
due to catheter blockages, 4 rats were excluded due to equipment failures, and 2 rats were 125 
excluded owing to a failure to learn the task (<25 infusions during training). 4 rats were 126 
excluded from the Yohimbine+CS relapse experiment as their test data were >2 s.d. from the 127 
group mean. 128 
 129 
  130 
7 
RESULTS 131 
Experiment 1: Disruption of spontaneous drug-seeking 132 
Differences at test could not be attributed to prior differences during training (Fig 1) as both 133 
groups learned to respond predominantly on the active lever and performed similarly prior to 134 
reactivation (MK-801 x Lever x Session: F(5.2,97.9)=0.20, p=0.97, η2p=0.010, BFinc<0.001; 135 
MK-801 x Lever: F(1,19)=0.27, p=0.61, η2p=0.014, BFinc=0.13; MK-801: F(1,19)=0.33, p=0.57, 136 
η2p=0.017, BFinc=0.12). 137 
48 hrs after training, rats were injected i.p. with MK-801 (or saline vehicle) 30 minutes 138 
prior to a short VR5 reactivation session in which the reward contingency was altered. 139 
Responding of MK-801 treated individuals was generally reduced (MK-801: F(1,19)=6.97, 140 
p=0.016, η2p=0.27, BFinc=3.17); however, rats still showed some evidence of discrimination 141 
between the levers (MK-801 x Lever: F(1,19)=3.19, p=0.090, η2p=0.14, BFinc=3.87). 142 
On the following day spontaneous cocaine seeking performance was tested in 143 
extinction, in the absence of cocaine or the CS. MK-801-treated rats showed poorer 144 
discriminated responding on the active vs inactive lever across the test session (MK-801 x 145 
Lever: F(1,19)=12.7, p=0.002, η2p=0.40, BFinc=67.9; MK-801 x Lever x Bin: F(1,19)=0.48, 146 
p=0.50, η2p=0.025, BFinc=1.87). This suggests MK-801 successfully disrupted instrumental 147 
cocaine memory reconsolidation. 148 
 149 
Experiment 2: CS-induced relapse 150 
A second cohort of rats was trained as before with no group differences prior to reactivation 151 
and drug administration (Fig 2; MK-801 x Lever x Session: F(3.3,36.8)=0.44, p=0.75, 152 
η2p=0.038, BFinc=0.001; MK-801 x Lever: F(1,11)=0.12, p=0.74, η2p=0.011, BFinc=0.099; MK-153 
801: F(1,11)=0.36, p=0.56, η2p=0.031, BFinc=0.12). 154 
8 
After a 48-hr rest period, rats were administered MK-801 or saline as previously prior 155 
to a VR5 reactivation. There were no significant group differences in lever responding (MK-156 
801 x Lever: F(1,11)=1.46, p=0.25, η2p=0.12, BFinc=1.44); however as previously observed, 157 
response rates were generally, although not significantly, lower in the MK-801 group (MK-158 
801: F(1,11)=3.08, p=0.11, η2p=0.22, BFinc=0.95). 159 
At test, active responses triggered a 1-sec presentation of the CS light above the lever. 160 
Under these test conditions, there was no evidence for an impairment in discriminated 161 
responding in previously MK-801-treated rats (MK-801 x Lever: F(1,11)=0.015, p=0.90, 162 
η2p=0.001, BFinc=0.35; MK-801 x Lever x Bin: F(1,11)=0.71, p=0.42, η2p=0.061, BFinc=0.061; 163 
MK-801: F(1,11)=0.65, p=0.44, η2p=0.056, BFinc=0.33). Therefore, the cocaine-associated light 164 
cue was able to recover cocaine seeking. 165 
 166 
Experiment 3: Yohimbine-induced relapse 167 
A third cohort learned to self-administer cocaine, with treatment groups performing similarly 168 
prior to reactivation (Fig 3; MK-801 x Lever x Session: F(9,117)=1.01, p=0.44, η2p=0.072, 169 
BFinc=0.009; MK-801 x Lever: F(1,13)=0.53, p=0.48, η2p=0.039, BFinc=0.35; MK-801: 170 
F(1,13)=0.19, p=0.67, η2p=0.014, BFinc=0.20). 171 
At reactivation there was again evidence for an acute overall reduction in responding 172 
following MK-801 administration (MK-801: F(1,13)=5.91, p=0.030, η2p=0.31, BFinc=1.99), and 173 
although it is somewhat unclear statistically whether this was specific to either lever (MK-174 
801 x Lever: F(1,13)=2.73, p=0.122, η2p=0.17, BFinc=3.1), numerically the reduction was 175 
apparent across both levers. 176 
30 minutes prior to testing all rats were injected with yohimbine. Under these test 177 
conditions MK-801-treated rats had impaired discrimination (MK-801 x Lever: F(1,13)=7.51, 178 
p=0.017, η2p=0.37, BFinc=48.2) that was time-dependent within the session (MK-801 x Lever 179 
9 
x Bin: F(1,13)=4.62, p=0.051, η2p=0.26, BFinc=26.7). Analysis of simple effects revealed a 180 
more obvious effect in the first half of the session (MK-801 x Lever: F(1,13)=6.52, p=0.024, 181 
η2p=0.33, BFinc=16.7) than in the second half (MK-801 x Lever: F(1,13)=3.03, p=0.11, 182 
η2p=0.19, BFinc=2.1; MK-801: F(1,13)=2.47, p=0.14, η2p=0.16, BFinc=1.5). Therefore, 183 
yohimbine failed to recover the MK-801-induced deficit in instrumental cocaine seeking. 184 
 185 
Experiment 4: Yohimbine+CS-induced relapse 186 
Another cohort learned to self-administer cocaine as before with no significant group 187 
differences (Fig 4; MK-801 x Lever x Session: F(4.4,122.7)=0.66, p=0.64, η2p=0.023, 188 
BFinc=0.086; MK-801 x Lever: F(1,28)=1.40, p=0.25, η2p=0.048, BFinc=2.06; MK-801: 189 
F(1,28)=1.32, p=0.26, η2p=0.045, BFinc=0.84; YOH x Lever x Session: F(4.3,119.6)=0.30, p=0.89, 190 
η2p=0.011, BFinc<0.001; YOH x Lever: F(1,28)=0.31, p=0.58, η2p=0.011, BFinc=0.096; YOH: 191 
F(1,28)<0.001, p=0.97, η2p=0.000, BFinc=0.10). 192 
48 hrs after training rats were, as previously, injected with MK-801 or vehicle prior to 193 
reactivation. There was no significant acute effect of MK-801 treatment during this session 194 
(MK-801 x Lever: F(1,28)=0.076, p=0.79, η2p=0.003, BFinc=0.57; MK-801: F(1,28)=1.76, 195 
p=0.20, η2p=0.059, BFinc=0.57). In contrast, the groups that would subsequently be treated 196 
with yohimbine responded more than those to be administered saline (YOH x Lever: 197 
F(1,28)=10.9, p=0.003, η2p=0.28, BFinc=47.9), which was surprising given the lack of any 198 
difference during training. However, this effect was only observed in MK-801-injected rats 199 
(YOH x Lever: F(1,13)=9.30, p=0.009, η2p=0.42, BFinc=20.1), and not in the saline control 200 
condition (YOH x Lever: F(1,13)=2.24, p=0.16, η2p=0.15, BFinc=1.30). 201 
Rats were injected with yohimbine or vehicle 30 min prior to a test, in which active 202 
lever presses were reinforced by the light CS. In order to evaluate the capacity of yohimbine 203 
to elevate responding at test, we analysed first the overall effect of yohimbine (Fig. 4B & C). 204 
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There was evidence that yohimbine did increase performance across the test (YOH x Lever: 205 
F(1,28)=4.46, p=0.044, η2p=0.14, BFinc=3.84; YOH x Lever x Bin: F(1,28)=0.005, p=0.95, 206 
η2p=0.000, BFinc=0.22). Planned comparisons revealed evidence for the yohimbine-induced 207 
enhancement in the non-MK-801-treated rats (YOH x Lever: F(1,13)=4.98, p=0.044, η2p=0.28, 208 
BFinc=11.9; YOH x Lever x Bin: F(1,13)=0.34, p=0.57, η2p=0.025, BFinc=0.53), but not in the 209 
MK-801-treated group (YOH x Lever: F(1,13)=0.37, p=0.55, η2p=0.028, BFinc=0.33; YOH x 210 
Lever x Bin: F(1,13)=0.10, p=0.75, η2p=0.008, BFinc=0.08; YOH: F(1,13)=0.38, p=0.55, 211 
η2p=0.029, BFinc=0.33). Therefore, there was evidence that pre-test yohimbine was able to 212 
elevate cocaine-seeking. 213 
There was no overall effect of MK-801 (MK-801 x Lever: F(1,28)=2.01, p=0.17, 214 
η2p=0.067, BFinc=0.74; MK-801 x Lever x Bin: F(1,28)=0.082, p=0.78, η2p=0.003, BFinc=0.11; 215 
MK-801: F(1,28)=1.01, p=0.33, η2p=0.035, BFinc=0.48). Planned comparisons revealed no 216 
effect of MK-801 in the non-yohimbine groups (Fig 4B; MK-801 x Lever: F(1,14)=0.004, 217 
p=0.95, η2p=0.000, BFinc=0.30; MK-801 x Lever x Bin: F(1,14)=0.24, p=0.63, η2p=0.017, 218 
BFinc=0.072; MK-801: F(1,14)=0.009, p=0.93, η2p=0.001, BFinc=0.28), with somewhat less 219 
clear evidence in the yohimbine-treated groups (Fig 4C; MK-801 x Lever: F(1,12)=3.26, 220 
p=0.096, η2p=0.21, BFinc=0.74; MK-801 x Lever x Bin: F(1,12)=0.058, p=0.81, η2p=0.005, 221 
BFinc=0.099; MK-801: F(1,12)=1.67, p=0.22, η2p=0.12, BFinc=0.48). Therefore, it remains 222 
unclear whether combination of yohimbine and the CS was able to recover the lever 223 
responding fully. 224 
 225 
Experiment 5: Cocaine-induced relapse 226 
The final cohort learned to self-administer cocaine. There was evidence for an overall 227 
difference between the groups in their discriminated responding (Fig 5; MK-801 x Lever: 228 
F(1,14)=4.87, p=0.044, η2p=0.26, BFinc=792.0; MK-801 x Lever x Session: F(2.3,32.5)=1.08, 229 
11 
p=0.36, η2p=0.071, BFinc=0.009), with the rats to be injected with MK-801 performing to a 230 
higher level. This is somewhat problematic for evaluating post-learning differences in 231 
behaviour, and may explain the lack of acute effect of MK-801 on the VR5 reactivation 232 
session (MK-801 x Lever: F(1,14)=0.60, p=0.45, η2p=0.041, BFinc=0.70; MK-801: F(1,14)=0.33, 233 
p=0.57, η2p=0.023, BFinc=0.46), in that the MK-801-injected rats might have been expected to 234 
perform better than saline controls on the basis of training history. 235 
24 hours after reactivation, rats were injected i.p. with cocaine immediately before 236 
testing commenced. Under these test conditions, there was no evidence for an impairment in 237 
discriminated responding in previously MK-801-treated rats (MK-801 x Lever: F(1,14)=0.022, 238 
p=0.65, η2p=0.016, BFinc=0.36; MK-801 x Lever x Bin: F(1,14)=1.12, p=0.31, η2p=0.074, 239 
BFinc=0.064; MK-801: F(1,14)=0.004, p=0.95, η2p=0.000, BFinc=0.30). In an exploratory 240 
analysis to control partially for the different training history between the two groups, we 241 
reanalysed the total active lever responses across the test session using an ANCOVA, with 242 
total rewards earned during training as the covariate. This analysis provided further support 243 
for there being no difference between the groups at test (F(1,13)=0.035, p=0.85, η2p=0.003, 244 
BFinc=0.45). Therefore, cocaine priming was able to recover cocaine seeking. 245 
 246 
  247 
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DISCUSSION 248 
In the present studies, the combination of instrumental cocaine memory reactivation in a brief 249 
VR5 session and pre-reactivation systemic treatment with MK-801 reduced subsequent 250 
cocaine-seeking under certain test conditions. Reduced cocaine seeking was observed in a 251 
test of spontaneous drug seeking, as well as following pharmacological challenge with 252 
yohimbine. However, apparently normal seeking behaviour was observed in tests of cue-253 
induced and cocaine-induced cocaine seeking. Therefore, while the targeting of instrumental 254 
cocaine memory reconsolidation has complementary beneficial effects to disruption of 255 
pavlovian cocaine memory reconsolidation, both appear not to confer resistance to cocaine-256 
induced relapse. 257 
 258 
Administration of the NMDAR antagonist MK-801 prior to VR5 reactivation reduced long-259 
term responding for cocaine on the next day, when tested in the absence of explicit 260 
precipitants of relapse. This is consistent with our previous observations that memory 261 
reactivation involving a shift to a variable reward contingency successfully destabilizes 262 
instrumental sucrose memory, allowing reconsolidation to be disrupted with MK-801 [19]. A 263 
similar finding was also observed for weakly-trained instrumental memories for both sucrose 264 
and cocaine reward [18]. Here we implemented an adapted protocol in which our VR5 265 
reactivation was given 48 hrs after training, as delaying the reactivation session appears to 266 
facilitate destabilisation in sucrose settings (Cheng C., Lee J.L.C. & Exton-McGuinness 267 
M.T.J., unpublished observations). Given our previous demonstration that the decrease in 268 
lever pressing is due to disruption of instrumental memory [18], it is highly likely that the 269 
present reduction in cocaine seeking is similarly caused by destabilisation and disruption of 270 
instrumental cocaine memory. That said, the seemingly consistent effect of pre-reactivation 271 
MK-801 to lower responding during the reactivation session is in marked contrast to the 272 
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elevation of responding observed in our previous instrumental sucrose memory 273 
reconsolidation study [19], and might point to alternative interpretations. If MK-801 were 274 
acutely affecting memory retrieval, there remains the possibility that such an impairment may 275 
be long-lasting. Alternatively, the effect of MK-801 to increase locomotor activity [30] could 276 
become linked to memory retrieval, thereby impacting upon later test performance. This latter 277 
suggestion bears some similarity to the recent hypothesis that reconsolidation impairments 278 
can be interpreted not as mnemonic disruptions, but as the integration of new information that 279 
influences subsequent memory retrieval [31]. 280 
 281 
Importantly for future clinical application, reconsolidation-disruption of lever pressing was 282 
not recovered by the anxiogenic α2 antagonist yohimbine. Yohimbine has been observed to 283 
reinstate extinguished lever pressing, for cocaine [25], nicotine [32] and heroin [33] at the 284 
doses used here. However, in the present study no recovery of responding was observed in 285 
previously MK-801-treated animals. This result indicates an inability of (at least 286 
pharmacological) stress to rescue the reconsolidation deficit, even though the same stress 287 
induction manipulation was able to elevate test responding in a control condition, compared 288 
to vehicle pre-treatment (CS+YOH experiment). 289 
 290 
In contrast to the effects of yohimbine, response-contingent CS presentation rescued 291 
performance to control levels. This demonstrates firstly that any deficits in lever pressing 292 
caused by MK-801 administration were not due to any motor incapacity to respond, as 293 
cocaine seeking was recovered to apparently normal levels under certain test conditions. 294 
Secondly, pavlovian cue-cocaine memory was evidently spared by the MK-801 + VR5 295 
reactivation reconsolidation manipulation, as the cocaine cue retained its ability to modulate 296 
cocaine seeking. This implies that pavlovian CS associations were not destabilised by the 297 
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VR5 reactivation session and demonstrates that instrumental and pavlovian memories that 298 
share the same rewarding outcome can be selectively destabilised. This complements 299 
previous demonstrations that reactivation sessions promoting the destabilisation of pavlovian 300 
CS-cocaine associations do not affect the underlying lever pressing, suggesting intact 301 
instrumental memory and hence selectivity to pavlovian memory destabilisation [13; 29]. 302 
While these observations reinforce our conclusion that instrumental memory was disrupted in 303 
the present study, they also raise an important issue for clinical translation in that the 304 
destabilisation and/or reconsolidation of both pavlovian and instrumental memories have not 305 
yet been shown to be possible within a single reactivation session. An important caveat, 306 
however, to these conclusions is the apparent discrepancy in the training history of the CS 307 
relapse rats in our experiment 2 (=216 total cocaine infusions), compared to the rats in the 308 
other experiments (=148-164 across experiments). It is possible that the greater strength of 309 
the conditioned instrumental cocaine memory resulting from the increased number of cocaine 310 
infusions may have provided a boundary condition on instrumental memory destabilisation 311 
under the present reactivation parameters. If this were the case, the apparent recovery with 312 
CS presentation would in fact, reflect a lack of underlying instrumental impairment, leaving 313 
open the possibility that disrupted instrumental cocaine memory reconsolidation is not 314 
recovered by response-contingent CS presentation. Such a conclusion is, however, weakened 315 
by our observations in experiment 4, in which the groups treated with vehicle, rather than 316 
yohimbine, also show no evidence for an effect of MK-801 in a test of cue-induced relapse 317 
despite the markedly reduced cocaine intake history. 318 
 319 
It is particularly notable that our reactivation protocol did not destabilise pavlovian memory, 320 
as previous studies have successfully destabilised cocaine memory with simple brief CS 321 
exposure [29] and our VR5 reactivation also included CS presentation. Operationally it 322 
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appears that which memory trace is destabilised depends upon the functional features of the 323 
reactivation (i.e. what new information is presented). Changing the response-reward 324 
contingency destabilizes instrumental memory [19], while altering cue-reward contingency 325 
causes pavlovian memories to undergo reconsolidation [29; 34]. However, it remains unclear 326 
how destabilisation of pavlovian and instrumental memories interact with each other. 327 
 328 
Returning to the lack of stress-induced relapse, it is worth noting that yohimbine, and stress 329 
more generally, appear to have strong effects upon CS-mediated forms of reinstatement [25; 330 
33]. Our results do not show clearly whether or not yohimbine, while ineffective in 331 
recovering spontaneous cocaine seeking, is able to act synergistically to enhance cue-induced 332 
relapse. In our CS+YOH experiment, yohimbine did not elevate cue-induced cocaine seeking 333 
in MK-801-treated rats, even though it did increase responding in saline-treated controls. This 334 
suggests an inability of stress to potentiate cue-induced cocaine seeking following 335 
instrumental memory reconsolidation impairment. In contrast, there was little statistical 336 
evidence for an effect of MK-801, compared to saline, on yohimbine-stimulated cue-induced 337 
cocaine seeking at test, indicating that yohimbine might be able to recover behaviour to near-338 
normal levels. Inspection of the numerical results, however, suggest that the MK-801-treated 339 
rats did respond at lower levels than saline controls. Moreover, the failure of yohimbine to 340 
elevate seeking in MK-801-treated rats was certainly not due to any ceiling effect. Therefore, 341 
our results are most consistent with the conclusion that the previous failure of yohimbine to 342 
recover impaired cocaine seeking is not simply due to the absence of the CS at test. 343 
 344 
In contrast to yohimbine, and similarly to cue-induced relapse, cocaine priming was effective 345 
in recovering cocaine seeking at test. It should be noted that the cocaine-induced relapse test 346 
was conducted in the absence of explicit cues, a setting previously demonstrated to attenuate 347 
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amphetamine-primed reinstatement of amphetamine seeking [35]; nevertheless, there was 348 
evidence that cocaine priming did quantitatively elevate responding, at least with visual 349 
inspection of the MK-801 groups. 350 
 351 
The present pattern of results, with protection afforded only to stress-induced relapse, informs 352 
the important question of how cocaine priming and response-contingent CS presentation 353 
restored cocaine-seeking, given the background of an instrumental memory impairment. 354 
There are several potential accounts for such recovery. A first explanation focusses on the 355 
capacity of cues and cocaine to induce craving for the cocaine outcome, which can drive 356 
instrumental responding [36; 37]. However, such an account relies upon responding being 357 
only partially disrupted, as was seemingly the case in our results. Why recovery is 358 
statistically complete, rather than demonstrating enhancement of impaired responding but to 359 
lower levels than control, is unclear but may simply reflect ceiling effects, rather than a true 360 
complete recovery. Nevertheless, the lack of recovery following yohimbine treatment is not 361 
easily explained within a craving framework, as stress has similarly been argued to 362 
precipitate relapse via induction of craving [38] and yohimbine can similarly induce objective 363 
and subjective stress, and accompanying drug-craving [24]. Perhaps then, a focus on drug 364 
sensitization may be more relevant, given first the difficulty in applying the concept of 365 
craving to rodent behaviour, and more importantly the dissociation between CS and cocaine 366 
effects on mesocorticolimbic dopamine, as opposed to yohimbine effects on CRF release [39; 367 
40; 41]. Moreover, while drug self-administration can sensitize stress response systems [42], 368 
resulting in enhanced stress-induced responding [43; 44], the latter are typically observed 369 
with longer access to cocaine or longer training histories than those used in the present study. 370 
 371 
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A second explanation for the recovery in cue- and cocaine-induced relapse tests appeals to 372 
the debate surrounding the nature of reconsolidation impairments. While traditionally 373 
considered to reflect storage impairments [2], it has also been argued that performance 374 
deficits result from state-dependent learning effects [45] or, more recently, integration of new 375 
information [46]. The latter hypotheses emphasise observations of recovery from amnesia. 376 
Cocaine-primed and cue-induced reinstatement are predicated, at least in part, on the capacity 377 
of cocaine and cues to remind and reinstate the extinguished and inhibited instrumental 378 
memories [40]. Yohimbine-induced stress would not necessarily be expected to act as a 379 
reminder for the disrupted instrumental memory, and so the lack of recovery in the present 380 
results might be taken as support for retrieval impairment accounts of instrumental memory 381 
reconsolidation deficits. However, the different nature of stress-induced reinstatement might 382 
also point towards reconsolidation being a storage deficit in the current study. Stress has been 383 
argued, albeit typically when discussing footshock stress, to interfere with behavioural 384 
inhibition, thereby releasing instrumental responding from inhibition and leading to relapse 385 
[15]. While this can explain stress-induced reinstatement of instrumental responding that is 386 
under inhibition, either following extinction or other forms of retrieval inhibition, it would 387 
mean that stress would not be expected to recover a genuine impairment in instrumental 388 
memory storage.  389 
 390 
Notably instrumental behaviours can be mediated via either a ‘goal-directed’ Action–391 
Outcome (A–O) memory, or a Stimulus–Response (S–R) ‘habit’ [47]. Previous studies of 392 
reconsolidation have not demonstrated the disruption of more than one association following 393 
a single reactivation and drug treatment. Therefore, it is perhaps likely that only one of the 394 
A–O and S–R memories was destabilised and its reconsolidation impaired. Given our 395 
conclusion in sucrose seeking that reactivation and MK-801 impaired the S–R association 396 
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[19], we might assume that the A–O memory remained intact. This adds a further level of 397 
complexity to the explanation for recovery of responding, as it might not reflect recovery of 398 
the impaired S–R association, but rather activation/enhancement of the preserved A–O 399 
memory, especially as goal-directed responding appears to be actively inhibited in the course 400 
of the development of S–R habits [48]. Such an activation might be achieved via a reminder 401 
process, for which exposure to the CS and cocaine would again be expected to be effective. 402 
In contrast, there is little evidence that stress can activate instrumental responding; for 403 
example, single behavioural stress prior to a test for pavlovian-instrumental transfer test did 404 
not increase baseline instrumental responding [49]. 405 
 406 
In summary, reconsolidation-disruption of instrumental memory supporting cocaine-seeking 407 
can protect against stress-induced relapse, as well as diminish spontaneous rates of 408 
responding. However, little protection is afforded to cue-induced and cocaine-induced 409 
relapse. This leaves open the possibility that combined targeting of both instrumental and 410 
pavlovian memories might provide greater resistance to relapse. Moreover, a memory 411 
reactivation through non-contingent administration of cocaine can protect against cocaine-412 
induced relapse [50]. Interestingly, if it is the case that the targeting of instrumental memory 413 
reconsolidation disrupts selectively the S–R ‘habit’ associations that are believed to be key in 414 
driving addiction [8], this may leave behaviour under adaptive goal-directed control. This 415 
highlights the importance to translating the current findings into experimental settings that 416 
evaluate addition-like behaviour [e.g. 51], as simple cocaine seeking does not necessarily 417 
afford insight into whether the measured behaviour is genuinely maladaptive. 418 
 419 
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FIGURE LEGENDS 560 
 561 
Fig 1. Long-term lever pressing was significantly impaired at test following administration 562 
MK-801 in conjunction with a reactivation session. (A) Schematic of the experiment. (B) 563 
Rats learned to self-administer cocaine over training days 1-10 (T1-T10). At reactivation (R), 564 
overall responding was acutely reduced by MK-801 (n=12) administration compared to 565 
saline-injected controls (n=9), however this was not specific to either lever. In a 90-minute 566 
extinction test, previously MK-801 treated rats made significantly fewer responses on the 567 
active (previously cocaine paired). Data is presented as summary mean ± SEM. 568 
 569 
Fig 2. Presentation of a cocaine-paired CS maintained lever pressing at test, regardless of 570 
prior disruption of reconsolidation with MK-801. (A) Schematic of the experiment. (B) Rats 571 
acquired cocaine seeking successfully over training days 1-10 (T1-T10). At reactivation (R), 572 
lever pressing was slightly reduced by MK-801 (n=7) compared to saline controls (n=6), 573 
although this was not statistically significant. During testing, active lever responses triggered 574 
a 1 second presentation of the cue light. This was sufficient to recover responding of MK-801 575 
treated rats to control levels. Data is presented as summary mean ± SEM. 576 
 577 
Fig 3. Induction of stress using the α2 antagonist yohimbine failed to reinstate lever pressing 578 
following reconsolidation-disruption with MK-801. (A) Schematic of the experiment. (B) 579 
Rats learned to lever press for cocaine over training days 1-10 (T1-T10). At reactivation (R), 580 
overall lever pressing was acutely reduced by MK-801 (n=7) compared to saline controls 581 
(n=8), however this was not specific to either lever. 30 minutes prior to testing all rats were 582 
injected with yohimbine and tested in extinction (with no discrete stimuli present). Rats 583 
previously treated with MK-801 remained significantly impaired, suggesting stress is not 584 
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sufficient to rescue performance following disruption of instrumental memory. Data is 585 
presented as summary mean ± SEM. 586 
 587 
Fig 4. Administration of yohimbine did elevate instrumental responding in the presence of 588 
the CS, but not obviously in MK-801-treated rats. (A) Schematic of the experiment. (B) Rats 589 
receiving vehicle prior to test. (C) Rats receiving yohimbine prior to test. Rats learned to 590 
lever press for cocaine over training days 1-10 (T1-T10). At reactivation (R), there was no 591 
acute effect of MK-801 on performance, but the groups did differ depending on whether they 592 
subsequently received yohimbine. 30 minutes prior to testing rats were injected with 593 
yohimbine or vehicle and were tested with active lever presses reinforced by the CS. 594 
Yohimbine elevated test responding, more obviously in saline-treated rats. CS presentation 595 
recovered responding in the absence of yohimbine, but less obviously so with pre-test 596 
yohimbine. Data is presented as summary mean ± SEM (yohimbine groups: n=7; vehicle 597 
groups: n=8). 598 
 599 
Fig 5. Administration of a cocaine-priming injection successfully rescued lever pressing on 600 
the active drug-lever, following MK-801 induced disruption of reconsolidation. (A) 601 
Schematic of the experiment. (B) Rats acquired cocaine seeking successfully over the 602 
training period (T1-T10), although there were differences between the groups. At reactivation 603 
(R), overall lever pressing was slightly reduced by MK-801 administration (n=7), although 604 
this was not significantly different to saline controls (n=9). Immediately prior to testing rats 605 
were injected with 10 mg/kg cocaine, which subsequently rescued responding on the active 606 
lever in the MK-801 group. There was no difference at test between the groups, even when 607 
corrected for training history. Data is presented as summary mean ± SEM. 608 
 609 
